AlloVir to Present at the Piper Sandler 35th Annual Healthcare Conference

Rhea-AI Summary

AlloVir, Inc. (Nasdaq: ALVR) to participate in fireside chat at Piper Sandler 35th Annual Healthcare Conference. CEO Diana Brainard, M.D. to present at 10:00 a.m. ET on November 28, 2023. Webcast and replay available on AlloVir website.

WALTHAM, Mass.--(BUSINESS WIRE)-- AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 35^th Annual Healthcare Conference in New York City, NY on Tuesday, November 28, 2023 at 10:00 a.m. ET.

A live webcast and archived replay of the presentation will be available on the Investors & Press section of the AlloVir website at https://ir.allovir.com.

About AlloVir

AlloVir is a leading late-clinical stage cell therapy company focused on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company's innovative and proprietary technology platform leverages off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir's technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio. For more information, visit www.allovir.com or follow us on Twitter/X or LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231116711808/en/

Media and Investor:

ir@allovir.com

Source: AlloVir, Inc.

FAQ

What is AlloVir, Inc. participating in?

AlloVir, Inc. is participating in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference.

Who will be presenting at the conference?

Dr. Diana Brainard, the Chief Executive Officer of AlloVir, Inc., will be presenting at the conference.

When will the presentation take place?

The presentation will take place at 10:00 a.m. ET on November 28, 2023.

Where can the webcast and replay be accessed?

The webcast and archived replay of the presentation will be available on the Investors & Press section of the AlloVir website at https://ir.allovir.com.